Cartesian Therapeutics shares rose 8.3% due to the US Food and Drug Administration's “rmat” label for treating autoimmune diseases
Cartesian Therapeutics股价上涨8.3％原因是美国食品药品管理局发布的自身免疫性疾病治疗的 “rmat” 标签
Cartesian Therapeutics shares rose 8.3% due to the US Food and Drug Administration's “rmat” label for treating autoimmune diseases
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.